Capstone Therapeutics Corp.
|
-36.39 USD
|
99.45%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
96.276%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
103.361%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-1392.537%
|
Qrons Inc.
|
-0.06 USD
|
-243.053%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
67.742%
|
CSL Limited
|
2.73 USD
|
107.326%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
101.932%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
91.189%
|
Regen BioPharma, Inc.
|
0.26 USD
|
176.923%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-247.826%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-1900.0%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-523.053%
|
Burzynski Research Institute, Inc.
|
-0.01 USD
|
-1860.784%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-13233.333%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
23.077%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.606%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-288.35%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
92.754%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-128.833%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-743.882%
|
Mesoblast Limited
|
-0.09 USD
|
-124.467%
|
Marizyme, Inc.
|
-1.44 USD
|
86.111%
|
Genus plc
|
0.12 USD
|
266.667%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
91.416%
|
Pharming Group N.V.
|
-0.02 USD
|
-1142.236%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-28471.429%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
52.381%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-107.254%
|
ContraFect Corporation
|
-124.97 USD
|
99.84%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-376.19%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1566.667%
|
IMV Inc.
|
-4.37 USD
|
95.423%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-464.972%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-199900.0%
|
ONE Bio Corp.
|
1.43 USD
|
113.986%
|
Accustem Sciences Inc.
|
-0.34 USD
|
41.176%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
65.517%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-66.667%
|
Q BioMed Inc.
|
-0.08 USD
|
-156.082%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-184.495%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
39.394%
|
Biomind Labs Inc.
|
-0.02 USD
|
-1134.568%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.974%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-2602.703%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-905.025%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-8233.333%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-24900.0%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-2172.727%
|
GB Sciences, Inc.
|
-0.00 USD
|
-4778.049%
|
Alpha Cognition Inc.
|
-0.15 USD
|
-33.333%
|
HST Global, Inc.
|
-0.03 USD
|
-616.846%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-299.202%
|
Halberd Corporation
|
-0.00 USD
|
-199900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-28471.429%
|
Agentix Corp.
|
-0.04 USD
|
-471.429%
|
Resverlogix Corp.
|
-0.01 USD
|
-1308.451%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-165.252%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
96.124%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
15484.615%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
896.813%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-460.224%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-900.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-271.058%
|
Zenith Capital Corp.
|
-0.07 USD
|
-186.123%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-340.529%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-3074.603%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
94.695%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-39900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-119.058%
|
Kadimastem Ltd
|
-0.78 USD
|
74.359%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
95.745%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-1580.672%
|
LadRx Corporation
|
0.68 USD
|
129.412%
|
Cell Source, Inc.
|
-0.17 USD
|
-17.647%
|
Regen BioPharma, Inc.
|
0.29 USD
|
168.966%
|
NovAccess Global Inc.
|
-0.23 USD
|
13.043%
|
Affymax, Inc.
|
-0.39 USD
|
48.718%
|
Itoco Inc.
|
-0.01 USD
|
-2531.579%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-1900.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-7900.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-3471.429%
|
CytoDyn Inc.
|
-0.05 USD
|
-278.072%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-39900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-800.901%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.87%
|
SYBLEU INC
|
-0.02 USD
|
-1042.857%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-1308.451%
|
International Stem Cell Corporation
|
-0.02 USD
|
-1119.512%
|
Bioxytran, Inc.
|
-0.03 USD
|
-526.959%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-199900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
97.497%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
83.051%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-488.235%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-3074.603%
|
Neutra Corp.
|
-0.00 USD
|
-199900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.788%
|
PureTech Health plc
|
-2.38 USD
|
91.597%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
75.904%
|
IXICO plc
|
-0.02 USD
|
-719.672%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-252.113%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
85.185%
|
CSL Limited
|
5.47 USD
|
103.656%
|
Cellectis S.A.
|
-1.77 USD
|
88.701%
|